Buried Interface Strategies with Covalent Organic Frameworks for High-Performance Inverted Perovskite Solar Cells

© 2024 Wiley‐VCH GmbH.

Bibliographische Detailangaben
Veröffentlicht in:Advanced materials (Deerfield Beach, Fla.). - 1998. - 36(2024), 45 vom: 04. Nov., Seite e2408686
1. Verfasser: Yang, Shuai (VerfasserIn)
Weitere Verfasser: He, Jiandong, Chen, Zhihui, Luo, Hao, Wei, Jinbei, Wei, Xuyang, Li, Hao, Chen, Jiadi, Zhang, Weifeng, Wang, Jizheng, Wang, Shu, Yu, Gui
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2024
Zugriff auf das übergeordnete Werk:Advanced materials (Deerfield Beach, Fla.)
Schlagworte:Journal Article covalent organic frameworks interface modification perovskite solar cells power conversion efficiencies
Beschreibung
Zusammenfassung:© 2024 Wiley‐VCH GmbH.
Simultaneously controlling defects and film morphology at the buried interface is a promising approach to improve the power conversion efficiency (PCE) of inverted perovskite solar cells (PSCs). Here, two new donor‒acceptor type semiconductive covalent organic frameworks (COFs) are developed, COFTPA and COFICZ. The carefully designed COFs structure not only effectively regulates the morphology and defects of the buried interface film, but also realizes the alignment with the energy level of the perovskite film and enhances the extraction and transmission of the interface charge. Among them, COFICZ-treated inverted PSCs achieved a maxmum PCE of 25.68% (certified 25.14%), the inverted PCE reached a minimum PCE of 22.92% for 1 cm2 device. The efficiency of inverted PSCs with a 1.68 eV wide bandgap reached 22.92%, which is the highest datum of the reported 1.68 eV wide bandgap PSC. This lays the groundwork for the commercialization of perovskite/silicon tandem solar cells. Additionally, the unencapsulated devices demonstrated a high degree of stability during operational use and when subjected to conditions of high humidity and temperature
Beschreibung:Date Revised 07.11.2024
published: Print-Electronic
Citation Status PubMed-not-MEDLINE
ISSN:1521-4095
DOI:10.1002/adma.202408686